EXPEDITORS INTERNATIONAL OF WASHINGTON INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EXPEDITORS INTERNATIONAL OF WASHINGTON INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.90B | Feb 23, 2018 |
| FY2017 | Sep 30, 2017 | $1.80B | Feb 23, 2018 |
| FY2017 | Jun 30, 2017 | $1.67B | Feb 23, 2018 |
| FY2017 | Mar 31, 2017 | $1.55B | Feb 23, 2018 |
| FY2017 | Dec 31, 2016 | $1.64B | Feb 23, 2018 |
| FY2017 | Sep 30, 2016 | $1.56B | Feb 23, 2018 |
| FY2017 | Jun 30, 2016 | $1.48B | Feb 23, 2018 |
| FY2017 | Mar 31, 2016 | $1.42B | Feb 23, 2018 |
| FY2016 | Dec 31, 2015 | $1.60B | Feb 23, 2017 |
| FY2016 | Sep 30, 2015 | $1.65B | Feb 23, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.07B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $10.60B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $9.30B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $17.07B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $16.52B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $3.17B | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $2.46B | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $2.58B | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $1.90B | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $2.04B | Feb 19, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $458.74M | Feb 27, 2013 |
| FY2012 | Sep 30, 2012 | $465.14M | Feb 27, 2013 |
| FY2012 | Jun 30, 2012 | $453.65M | Feb 27, 2013 |
| FY2012 | Mar 31, 2012 | $446.57M | Feb 27, 2013 |
| FY2011 | Dec 31, 2011 | $476.16M | Feb 28, 2012 |
| FY2011 | Sep 30, 2011 | $493.85M | Feb 28, 2012 |
| FY2011 | Jun 30, 2011 | $472.56M | Feb 28, 2012 |
| FY2011 | Mar 31, 2011 | $453.92M | Feb 28, 2012 |
| FY2011 | Dec 31, 2010 | $453.36M | Feb 28, 2012 |
| FY2011 | Sep 30, 2010 | $458.74M | Feb 28, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $810.33M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $810.07M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $752.88M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.36B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.42B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $198.62M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $191.31M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $183.87M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $122.34M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $137.33M | Feb 19, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.05B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $939.93M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.82B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.91B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $281.81M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $251.95M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $247.63M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $159.06M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $180.34M | Feb 19, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $723.36M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.05B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $2.13B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $868.49M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $654.97M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $771.69M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $572.80M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $488.64M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $529.49M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.89B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.75B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $4.52B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $5.59B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $7.61B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $4.93B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $3.69B | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $3.31B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $3.12B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $2.79B | Feb 22, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.36B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.22B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2.39B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.11B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.49B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $2.66B | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $2.20B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.99B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $1.99B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.84B | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.93M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $7.93M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $7.93M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $7.93M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $7.93M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $7.93M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $7.93M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $7.93M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $7.93M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $7.93M | Feb 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.54B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.46B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2.58B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.31B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.62B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $2.60B | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $2.32B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.09B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $2.06B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.94B | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.31B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.15B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.51B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.03B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.73B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.53B | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.23B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $923.74M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $1.05B | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $974.44M | Feb 22, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 133.88M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 138.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 143.87M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 154.31M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 167.21M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 169.29M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | 169.62M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 171.58M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 176.37M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 179.86M | Feb 23, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $207.44M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $204.09M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $202.03M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $213.80M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $195.77M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $174.93M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $170.55M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $156.84M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $150.50M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $145.12M | Feb 22, 2019 |